We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pre-Analytical Protocols Compared for Serotonin Quantification

By LabMedica International staff writers
Posted on 24 Oct 2019
Print article
Image: The VACUETTE Venous K2EDTA blood collection tubes were found the most suitable for the pre-analytical conditions for serotonin assays (Photo courtesy of Greiner Bio-One).
Image: The VACUETTE Venous K2EDTA blood collection tubes were found the most suitable for the pre-analytical conditions for serotonin assays (Photo courtesy of Greiner Bio-One).
Serotonin (5-hydroxytryptamine) is an important neurotransmitter and neuromodulator, which affects many neurophysiological processes, mood and cognition, regulates motility and sensibility in the bowel, and has an essential role in regulating blood pressure.

Since only free plasma serotonin can bind to serotonin receptors and exert biological activity, it is important to have a reliable and simple pre-analytical procedure to prepare platelet-poor plasma (PPP) for quantification of non-platelet bound serotonin. Concentrations of serotonin in PPP may vary widely due to differences in pre-analytical procedures.

Clinical scientists at the University of Bergen (Bergen, Norway) and their colleagues collected blood samples in 3 mL VACUETTE K2EDTA tubes and 5 mL VACUETTE K2EDTA gel tubes for isolation of plasma from nine healthy adults recruited at Haukeland University Hospital (Bergen, Norway) in September 2015. Six pre-analytical protocols were compared for preparation of PPP from EDTA whole blood for quantification of serotonin.

Three combinations of centrifugation with a mild centrifugation of gel-free EDTA tubes followed by a stronger centrifugation were compared to single-stage centrifugation of EDTA tubes with separator gel and heat shock treatment of blood prior to centrifugation. All samples were analyzed for serotonin using the same enzyme linked immunosorbent assay (ELISA) method.

The team reported that in one method serotonin concentrations in PPP prepared by the method of a single centrifugation at 1800 ×g at 4 ⁰C was significantly different from PPP prepared by all other methods. The scientists found that a combination of a milder first centrifugation of gel-free EDTA-tubes to separate blood cells (100 or 200×g) followed by a stronger centrifugation of the supernatant (4,500 or 14,500×g) resulted in the lowest measured serotonin concentration in PPP.

The authors concluded that two successive centrifugations to produce PPP for serotonin analysis; first a mild centrifugation to avoid mechanical stress on the platelets, and next a stronger centrifugation to remove platelets, is superior to the use of gel tubes and heat shock treatment. Their interpretation was that the first centrifugation induced little mechanical stress on the blood platelets and the second centrifugation was sufficiently strong to prevent contamination of platelets in the PPP fraction. The study was published online on September 19, 2019, in the journal Practical Laboratory Medicine.

Related Links:
University of Bergen
Haukeland University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more